Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “TAM”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00784680
What this trial is testing

ATAC - Quality of Life Sub-Protocol

Who this might be right for
Quality of Life
AstraZeneca 308
Not applicableStudy completedNCT00814034
What this trial is testing

Coagulation Parameters in Postmenopausal Breast Cancer Patients Under Adjuvant Hormonal Therapy

Who this might be right for
Breast Cancer
Hellenic Breast Surgeons Society 306
Early research (Phase 1)Looking for participantsNCT06712810
What this trial is testing

Q702 for the Treatment of Patients With Hematologic Malignancies

Who this might be right for
Hematopoietic and Lymphatic System NeoplasmHistiocytic SarcomaMalignant Histiocytosis+34 more
Mayo Clinic 46
Post-approval studies (Phase 4)UnknownNCT02690870
What this trial is testing

Tamoxifen and Clomiphene Citrate in Mild Stimulation IVF

Who this might be right for
Infertility
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 210
Not applicableUnknownNCT00126464
What this trial is testing

Fulvestrant or Tamoxifen in Treating Postmenopausal Women Who Are Undergoing Surgery for Ductal Carcinoma in Situ of the Breast

Who this might be right for
Breast Cancer
Cedars-Sinai Medical Center 100
Not applicableUnknownNCT04292886
What this trial is testing

Thin Endometrium Undergoing Frozen-thawed Embryo Transfer

Who this might be right for
Thin Endometrium
Nanjing University 120
Large-scale testing (Phase 3)Not Yet RecruitingNCT06404775
What this trial is testing

External Mastalgia-oil Versus Oral Tamoxifen in Premenopausal Women with Severe Mastalgia

Who this might be right for
Mastalgia
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 456
Large-scale testing (Phase 3)Study completedNCT00003593
What this trial is testing

Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
Children's Oncology Group 254
Large-scale testing (Phase 3)Study completedNCT00309491
What this trial is testing

Randomized Study Comparing Tamoxifen vs. Tamoxifen + Aminoglutethimide in Postmenopausal Receptor-positive Patients

Who this might be right for
Early-stage Breast Cancer
Austrian Breast & Colorectal Cancer Study Group 2,021
Large-scale testing (Phase 3)Study completedNCT00002967
What this trial is testing

Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer

Who this might be right for
Breast Cancer
NSABP Foundation Inc
Early research (Phase 1)Study completedNCT00001436
What this trial is testing

A Phase I Study of OncoLAR® (Registered Trademark) (NSC 685403) With/Without Tamoxifen in Patients With Osteosarcoma

Who this might be right for
Neoplasm MetastasisOsteosarcoma
National Cancer Institute (NCI) 24
Not applicableEnded earlyNCT01239745
What this trial is testing

Aromasin® As Adjuvant Treatment In Postmenopausal Women With Invasive, Estrogen Receptor Positive Early Breast Cancer

Who this might be right for
Breast Neoplasms
Pfizer 46
Testing effectiveness (Phase 2)Study completedNCT02384239
What this trial is testing

Palbociclib in Combination With Fulvestrant or Tamoxifen as Treatment for Metastatic Breast Cancer

Who this might be right for
Metastatic Breast CancerHormone Receptor Positive
University of California, San Francisco 70
Testing effectiveness (Phase 2)Study completedNCT00229697
What this trial is testing

Phase II Metastatic ER+/PgR+ Nolvadex +/- Iressa Study

Who this might be right for
Breast Neoplasms
AstraZeneca 317
Testing effectiveness (Phase 2)Looking for participantsNCT06917313
What this trial is testing

FLASH-Breast: Evaluating the Efficacy of Fezolinetant in Reducing Vasomotor Symptoms in Women With Breast Cancer on Endocrine Therapy

Who this might be right for
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Yale University 92
Testing effectiveness (Phase 2)Study completedNCT00903162
What this trial is testing

Extended Endocrine Therapy for Premenopausal Women With Breast Cancer

Who this might be right for
Breast Cancer
Dana-Farber Cancer Institute 17
Testing effectiveness (Phase 2)Study completedNCT02344550
What this trial is testing

Study of GnRH-A [Leuprorelin(Lorelin Depot] Plus Leterozole +/- Everolimus for Premenopausal Women With Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Asan Medical Center 137
Testing effectiveness (Phase 2)Looking for participantsNCT06195306
What this trial is testing

Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction

Who this might be right for
Breast Atypical HyperplasiaBreast CarcinomaBreast Ductal Carcinoma In Situ+1 more
National Cancer Institute (NCI) 66
Large-scale testing (Phase 3)Study completedNCT01638247
What this trial is testing

Tamoxifen +/- GnRH Analogue vs Aromatase Inhibitor + GnRH Analogue in Male Breast Cancer Patients

Who this might be right for
Male Breast Cancer
GBG Forschungs GmbH 56
Post-approval studies (Phase 4)Study completedNCT00014638
What this trial is testing

Letrozole in Treating Postmenopausal Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Novartis
Next Page